Stocks
Cortexyme Financial Statements () |
||||||||||
| Cortexymesmart-lab.ru | % | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 06.08.2021 | 29.10.2021 | 01.03.2022 | 10.05.2022 | 09.08.2022 | 09.08.2022 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||
| Operating Income, bln rub | -21.8 | -21.7 | -89.9 | -21.6 | -16.3 | -149.4 | ||||
| EBITDA, bln rub | ? | -21.8 | -21.6 | -23.8 | -21.9 | -16.3 | -83.5 | |||
| Net profit, bln rub | ? | -21.8 | -21.7 | -89.9 | -21.7 | -16.6 | -149.9 | |||
| OCF, bln rub | ? | -17.6 | -17.3 | -14.4 | -16.1 | -47.9 | ||||
| CAPEX, bln rub | ? | 0.099 | 0.000 | 0.044 | 0.005 | 0.049 | ||||
| FCF, bln rub | ? | -17.7 | -17.3 | -14.5 | -16.1 | -47.9 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| OPEX, bln rub | 21.8 | 21.7 | 90.3 | 21.9 | 16.3 | 150.1 | ||||
| Cost of production, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| R&D, bln rub | 14.7 | 14.0 | 60.8 | 12.8 | 7.20 | 94.8 | ||||
| Interest expenses, bln rub | 0.000 | 0.000 | 0.000 | 0.072 | 0.590 | 0.662 | ||||
| Assets, bln rub | 161.4 | 147.4 | 133.2 | 116.1 | 117.9 | 117.9 | ||||
| Net Assets, bln rub | ? | 142.1 | 132.7 | 118.6 | 106.4 | 111.5 | 111.5 | |||
| Debt, bln rub | 0.773 | 0.610 | 0.420 | 0.339 | 0.133 | 0.133 | ||||
| Cash, bln rub | 130.0 | 114.4 | 106.8 | 91.5 | 94.7 | 94.7 | ||||
| Net debt, bln rub | -129.2 | -113.8 | -106.4 | -91.2 | -94.5 | -94.5 | ||||
| Ordinary share price, rub | 53.0 | 91.7 | 12.6 | 6.19 | 2.22 | 2.22 | ||||
| Number of ordinary shares, mln | 29.6 | 29.8 | 29.8 | 30.1 | 32 467 | 32 467 | ||||
| Market cap, bln rub | 1 568 | 2 728 | 376 | 187 | 72 077 | 72 077 | ||||
| EV, bln rub | ? | 1 439 | 2 615 | 269 | 95 | 71 982 | 71 982 | |||
| Book value, bln rub | 142 | 133 | 119 | 106 | 105 | 105 | ||||
| EPS, rub | ? | -0.74 | -0.73 | -3.02 | -0.72 | 0.00 | 0.00 | |||
| FCF/share, rub | -0.60 | -0.58 | -0.49 | -0.53 | 0.00 | 0.00 | ||||
| BV/share, rub | 4.80 | 4.46 | 3.98 | 3.53 | 0.00 | 0.00 | ||||
| FCF yield, % | ? | -3.63% | -2.27% | -16.8% | -35.1% | -0.07% | -0.07% | |||
| ROE, % | ? | -61.2% | -65.7% | -132.0% | -145.8% | -134.4% | -134.4% | |||
| ROA, % | ? | -53.8% | -59.1% | -117.5% | -133.6% | -127.2% | -127.2% | |||
| P/E | ? | -18.0 | -31.3 | -2.40 | -1.20 | -480.7 | -480.7 | |||
| P/FCF | -27.5 | -44.1 | -5.95 | -2.85 | -1 505 | -1 505 | ||||
| P/BV | ? | 11.0 | 20.6 | 3.17 | 1.75 | 687.7 | 687.7 | |||
| EV/EBITDA | ? | -16.9 | -30.7 | -2.99 | -1.07 | -861.6 | -861.6 | |||
| Debt/EBITDA | 1.51 | 1.34 | 1.18 | 1.02 | 1.13 | 1.13 | ||||
| R&D/CAPEX, % | 14 868% | 138 170% | 255 140% | 193 447% | ||||||
| Cortexyme shareholders | ||||||||||
